These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 27144518)

  • 21. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
    Zhang J; Li H; Wu Q; Chen Y; Deng Y; Yang Z; Zhang L; Liu B
    Redox Biol; 2019 Apr; 22():101116. PubMed ID: 30769285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer.
    Pei BX; Sun BS; Zhang ZF; Wang AL; Ren P
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1208-1216.e2. PubMed ID: 24907005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis.
    Yang Z; Zhang M; Peng R; Liu J; Wang F; Li Y; Zhao Q; Liu J
    Int J Colorectal Dis; 2020 Sep; 35(9):1651-1661. PubMed ID: 32666290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
    Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.
    Guo B; Cen H; Tan X; Ke Q
    BMC Med; 2016 Oct; 14(1):159. PubMed ID: 27745550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Role of Tumor-Stroma Ratio for Survival of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis.
    Zhang X; Ma H; Zhang L; Li F
    Pathol Oncol Res; 2021; 27():1610021. PubMed ID: 35132307
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated macrophages correlate with response to epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer.
    Chung FT; Lee KY; Wang CW; Heh CC; Chan YF; Chen HW; Kuo CH; Feng PH; Lin TY; Wang CH; Chou CL; Chen HC; Lin SM; Kuo HP
    Int J Cancer; 2012 Aug; 131(3):E227-35. PubMed ID: 22174092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.
    Carus A; Ladekarl M; Hager H; Pilegaard H; Nielsen PS; Donskov F
    Lung Cancer; 2013 Jul; 81(1):130-7. PubMed ID: 23540719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the immune molecular profile of the tumor microenvironment on the prognosis of NSCLC.
    Ying H; Hang Q; Cheng G; Yang S; Lai X; Fang M
    Oncol Lett; 2023 Mar; 25(3):131. PubMed ID: 36844625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
    Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
    J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of Tumor-Associated Macrophages in Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Shen H; Liu J; Chen S; Ma X; Ying Y; Li J; Wang W; Wang X; Xie L
    Front Oncol; 2021; 11():657318. PubMed ID: 34026635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Cell RNA Sequencing Reveals the Heterogeneity of Tumor-Associated Macrophage in Non-Small Cell Lung Cancer and Differences Between Sexes.
    Yang Q; Zhang H; Wei T; Lin A; Sun Y; Luo P; Zhang J
    Front Immunol; 2021; 12():756722. PubMed ID: 34804043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
    Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
    J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    Bisheshar SK; van der Kamp MF; de Ruiter EJ; Ruiter LN; van der Vegt B; Breimer GE; Willems SM
    Oral Oncol; 2022 Dec; 135():106227. PubMed ID: 36335818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis.
    Li J; Xie Y; Wang X; Li F; Li S; Li M; Peng H; Yang L; Liu C; Pang L; Zou H; Zhao J; Qi Y; Cao Y; Hu J
    Future Oncol; 2019 Jul; 15(19):2303-2317. PubMed ID: 31237146
    [No Abstract]   [Full Text] [Related]  

  • 38. CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer.
    Schmid S; Csanadi A; Kozhuharov N; Tchudjin M; Kayser C; Rawluk J; Passlick B; Werner M; Prasse A; Kayser G
    Anticancer Res; 2018 Jul; 38(7):3913-3918. PubMed ID: 29970512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma.
    Yanagawa N; Shikanai S; Sugai M; Koike Y; Asai Y; Tanji T; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    Thorac Cancer; 2023 Jul; 14(20):1911-1920. PubMed ID: 37208929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
    La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
    Int J Cancer; 2018 Oct; 143(7):1741-1752. PubMed ID: 29667169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.